GW Pharmaceuticals Plc American Depositary Shares
GWPH
GWPH was delisted on the 4th of May, 2021.
318 hedge funds and large institutions have $2.59B invested in GW Pharmaceuticals Plc American Depositary Shares in 2019 Q4 according to their latest regulatory filings, with 70 funds opening new positions, 111 increasing their positions, 73 reducing their positions, and 57 closing their positions.
52% more repeat investments, than reductions
Existing positions increased: 111 | Existing positions reduced: 73
23% more first-time investments, than exits
New positions opened: 70 | Existing positions closed: 57
1% more funds holding
Funds holding: 316 → 318 (+2)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
9% less capital invested
Capital invested by funds: $2.86B → $2.59B (-$271M)
23% less call options, than puts
Call options by funds: $138M | Put options by funds: $180M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
+$67.8M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$52.4M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$49.8M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$32.6M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$29.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PP
Prudential plc
London, England,
United Kingdom
|
-$102M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$81.1M |
| 3 |
Millennium Management
New York
|
-$73.6M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$33.3M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$31.9M |
GWPH Hedge Fund Activity: Q4 2019 in Review
318 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q4 2019, worth a combined $2.59B — down 9.5% from $2.86B a quarter earlier.
Buyers outnumbered sellers: 70 funds opened new GWPH positions and 57 closed out — a net gain of 13 holders — while 111 added to existing stakes and 73 trimmed.
The largest buyer was Consonance Capital Management, opening a new position worth an estimated $67.8M. The largest seller was Prudential plc, exiting entirely with an estimated $102M sold.
- 318 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q4 2019, up from 316 in Q3 2019.
- Funds reported $2.59B of GW Pharmaceuticals Plc American Depositary Shares stock for Q4 2019, down 9.5% quarter-over-quarter.
- 70 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q4 2019 and 57 closed out, a net change of +13 holders.
- The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q4 2019 was Consonance Capital Management, an estimated $67.8M added.
- The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q4 2019 was Prudential plc, an estimated $102M sold.
Based on aggregated 13F filings for Q4 2019.